Italia markets closed

PCAS SA (0NF7.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a portafoglio
12,88-5,43 (-29,64%)
Alla chiusura: 12:29PM GMT
Schermo intero
Chiusura precedente18,30
Aperto12,88
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno12,88 - 12,88
Intervallo di 52 settimane12,88 - 12,88
Volume75.000
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,55
Rapporto PE (ttm)N/D
EPS (ttm)-1,05
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    PCAS: NET SALES AS OF DECEMBER 31, 2021

    Ecully, January 27, 2022 NET SALES AS OF DECEMBER 31, 2021 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of December 31, 2021. The PCAS Group has generated consolidated net sales of €187.0 million as of December 31, 2021, a 3.7% decrease compared to the same period during the previous financial year (-2.6% at constant exchange rates). In millions

  • GlobeNewswire

    PCAS: Change of shareholders at Seqens - Appointment of a new Chief Executive Officer

    Ecully, December 16, 2021 CHANGE OF SHAREHOLDERS AT SEQENS APPOINTMENT OF A NEW CHIEF EXECUTIVE OFFICER Seqens announced on December 16, 2021 that the funds advised by SK Capital have become majority shareholders of the Group – alongside BPI France, Nov Santé Actions Non Cotées, Mérieux Equity Partners, Ardian, Eximium, and the executive management of Seqens. Concurrent with this investment, Seqens has combined with Wavelength Pharmaceuticals, an API manufacturer and CDMO group company, an exist

  • GlobeNewswire

    Pcas:

    Ecully, November 4, 2021 NET SALES AS OF SEPTEMBER 30, 2021 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2021. The PCAS Group had generated consolidated net sales of €142.4 million as of September 30, 2021, up 0.8% compared to the same period during the previous financial year (+2.5% at constant exchange rates). In millions of eu